Treace Medical Concepts, Inc. (TMCI): Revenue

Annual figures by period end, from SEC filings.

$212.69M
Year ended 2025-12-31
$205.31M
Trailing 12 months to 2026-06-30
+14.5%
3-year compound annual growth
+30.0%
5-year compound annual growth
2019-12-31: $39.42M2020-12-31: $57.37M2021-12-31: $94.42M2022-12-31: $141.84M2023-12-31: $187.12M2024-12-31: $209.36M2025-12-31: $212.69M$212.69M
2019-12-31 Revenue (USD) 2025-12-31
Period endedRevenueChange YoYSource filing
2025-12-31$212.69M+1.6%2026-02-27, From 2025-01-01
2024-12-31$209.36M+11.9%2026-02-27, From 2024-01-01
2023-12-31$187.12M+31.9%2026-02-27, From 2023-01-01
2022-12-31$141.84M+50.2%2025-02-27, From 2022-01-01
2021-12-31$94.42M+64.6%2024-02-27, From 2021-01-01
2020-12-31$57.37M+45.5%2023-03-08, From 2020-01-01
2019-12-31$39.42Mn/a2022-03-04, From 2019-01-01

Revenue at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedRevenueChange YoY
Treace Medical Concepts, Inc. (TMCI)2025-12-31$212.69M+1.6%
SI-BONE, Inc. (SIBN)2025-12-31$200.93M+20.2%
Cerus Corp (CERS)2025-12-31$233.80M+16.1%
Orthopediatrics Corp (KIDS)2025-12-31$236.35M+15.4%
Lemaitre Vascular Inc (LMAT)2025-12-31$249.60M+13.5%
Heartflow, Inc. (HTFL)2025-12-31$176.03M+39.9%
SkinHealth Systems Inc. (SKIN)2025-12-31$300.79M-10.0%
Neuronetics, Inc. (STIM)2025-12-31$149.16M+99.2%
PROCEPT BioRobotics Corp (PRCT)2025-12-31$308.05M+37.2%

Compare TMCI, SIBN, CERS, KIDS side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗